Camlin Fine Sciences Q1 Results: Earnings call scheduled for Aug 11, 2026
Camlin Fine Sciences Limited has announced a Q1 FY27 earnings conference call on August 11, 2026 at 5:00 PM IST to discuss unaudited financial results for the quarter ended June 30, 2026. The call will be led by Chairman & Managing Director Mr. Ashish Dandekar, Managing Director Mr. Nirmal Momaya, and CFO Mr. Santosh Parab. Dial-in access has been provided for participants across India, the USA, UK, Singapore, and Hong Kong. The intimation was filed by Company Secretary Rahul Sawale on August 4, 2026, in compliance with SEBI LODR Regulation 30.

*this image is generated using AI for illustrative purposes only.
Camlin Fine Sciences Limited has scheduled a Q1 FY27 earnings conference call on Tuesday, August 11, 2026 at 5:00 PM IST, to discuss the company's unaudited financial results for the quarter ended June 30, 2026. The intimation was filed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has clarified that discussions during the call will be based solely on publicly available information, and no unpublished price-sensitive information (UPSI) is intended to be discussed.
Call Details and Access Information
Investors and analysts are requested to pre-register for the call via the link provided by the company. The following dial-in access numbers have been made available for participation across multiple geographies:
| Access Type: | Details |
|---|---|
| Primary Number: | +91 22 6280 1309 / +91 22 7115 8210 |
| Toll Free – USA: | 1 866 746 2133 |
| Toll Free – UK: | 0 808 101 1573 |
| Toll Free – Singapore: | 800 101 2045 |
| Toll Free – Hong Kong: | 800 964 448 |
Senior Management Participants
The earnings call will feature the following senior management representatives from Camlin Fine Sciences:
- Mr. Ashish Dandekar – Chairman & Managing Director
- Mr. Nirmal Momaya – Managing Director
- Mr. Santosh Parab – Chief Financial Officer
RSVP and Investor Relations Contact
The call is being coordinated by Strategic Growth Advisors Pvt. Ltd. Interested participants may reach out to the investor relations team for further assistance:
| Contact Person: | Contact Number |
|---|---|
| Mr. Shrikant Sangani: | +91 9619595686 |
| Ms. Shaily Patwa: | +91 9819494608 |
The company has noted that the scheduled date of the call is subject to change due to exigencies on the part of analysts, investors, or the company. The filing was signed by Rahul Sawale, Company Secretary & VP Legal, on August 4, 2026.
Historical Stock Returns for Camlin Fine Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.37% | +2.24% | -4.77% | -22.87% | -52.23% | -27.36% |
How might Camlin Fine Sciences' Q1 FY27 performance reflect the broader recovery trends in the global specialty chemicals sector?
What specific operational or strategic initiatives will management highlight to address potential margin pressures in the upcoming quarter?
Will the earnings call provide updated guidance on capital expenditure plans for capacity expansion in key product lines?

































